Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has announced its participation in two major investor conferences in November 2024. The company's executives will participate in fireside chats at the Stifel Healthcare Conference in New York on November 19 and the Jefferies Healthcare Conference in London on November 21. Both presentations will be available via live webcast on the company's Investor Relations website, with archived versions accessible after the events.
Maravai LifeSciences (NASDAQ: MRVI), un fornitore globale di reagenti e servizi per le scienze della vita, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel novembre 2024. I dirigenti dell'azienda parteciperanno a colloqui informali durante la Stifel Healthcare Conference a New York il 19 novembre e la Jefferies Healthcare Conference a Londra il 21 novembre. Entrambe le presentazioni saranno disponibili tramite webcast dal vivo sul sito web Relazioni con gli Investitori dell'azienda, con versioni registrate accessibili dopo gli eventi.
Maravai LifeSciences (NASDAQ: MRVI), un proveedor global de reactivos y servicios de ciencias de la vida, ha anunciado su participación en dos importantes conferencias de inversores en noviembre de 2024. Los ejecutivos de la compañía participarán en charlas informales en la Stifel Healthcare Conference en Nueva York el 19 de noviembre y en la Jefferies Healthcare Conference en Londres el 21 de noviembre. Ambas presentaciones estarán disponibles a través de transmisión en vivo en el sitio web de Relaciones con Inversores de la empresa, con versiones archivadas accesibles después de los eventos.
Maravai LifeSciences (NASDAQ: MRVI)는 생명 과학 시약 및 서비스를 제공하는 글로벌 업체로서, 2024년 11월에 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사의 경영진은 11월 19일 뉴욕에서 열리는 Stifel Healthcare Conference와 11월 21일 런던에서 열리는 Jefferies Healthcare Conference에서 화상 대화에 참여할 예정입니다. 두 발표 모두 회사 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 제공되며, 행사 후에 아카이브 버전도 접근할 수 있습니다.
Maravai LifeSciences (NASDAQ: MRVI), un fournisseur mondial de réactifs et de services pour les sciences de la vie, a annoncé sa participation à deux grandes conférences pour investisseurs en novembre 2024. Les dirigeants de l'entreprise participeront à des discussions informelles lors de la Stifel Healthcare Conference à New York le 19 novembre et de la Jefferies Healthcare Conference à Londres le 21 novembre. Les deux présentations seront disponibles par webcast en direct sur le site web des Relations avec les Investisseurs de l'entreprise, avec des versions archivées accessibles après les événements.
Maravai LifeSciences (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen im Bereich der Lebenswissenschaften, hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im November 2024 angekündigt. Die Führungskräfte des Unternehmens werden an informellen Gesprächen auf der Stifel Healthcare Conference in New York am 19. November und der Jefferies Healthcare Conference in London am 21. November teilnehmen. Beide Präsentationen werden über einen Live-Webcast auf der Investor Relations-Website des Unternehmens verfügbar sein, mit Archive-Versionen, die nach den Veranstaltungen zugänglich sind.
- None.
- None.
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November.
On November 19, 2024, at 8:30 a.m. PST/ 11:30 a.m. EST, Kevin Herde, Chief Financial Officer, and Drew Burch, President, Nucleic Acid Production, will participate in a fireside chat at the Stifel Healthcare Conference in New York, NY.
On November 21, 2024, at 2:00 a.m. PST/ 9:00 a.m. GMT, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in London, England.
A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
FAQ
When is Maravai LifeSciences (MRVI) presenting at the Stifel Healthcare Conference in November 2024?
When is Maravai LifeSciences (MRVI) presenting at the Jefferies Healthcare Conference in November 2024?
Where can I watch Maravai LifeSciences (MRVI) November 2024 investor conference presentations?
